PRESS RELEASE published on 09/19/2023 at 11:00, 2 years 10 months ago Rentschler Biopharma appoints Benedikt von Braunmuehl as Chief Executive Officer and Tom Roberts as President and General Manager U.S.
PRESS RELEASE published on 09/13/2023 at 09:00, 2 years 10 months ago Rentschler Biopharma’s ATMP facility in UK receives MHRA approval
PRESS RELEASE published on 07/12/2023 at 10:00, 3 years ago Rentschler Biopharma SE : Dr. Dominik Kugelstadt joins as Head of Clinical and Commercial Manufacturing, Laupheim
PRESS RELEASE published on 06/01/2023 at 11:00, 3 years 2 months ago Rentschler Biopharma joins forces with Ikarovec to accelerate novel gene therapies for treatment of ophthalmic disease
PRESS RELEASE published on 04/12/2023 at 13:00, 3 years 3 months ago Rentschler Biopharma appoints Thomas aus dem Siepen as Global Head Digital Manufacturing and Automation
PRESS RELEASE published on 03/20/2023 at 11:00, 3 years 4 months ago Rentschler Biopharma’s service excellence recognized with CDMO Leadership Awards and Champion status
Published on 08/06/2026 at 03:35, 4 hours 36 minutes ago Tunkillia Upgrade Drilling – 39,000m Phase 2 Complete Targeting JORC Resource Classification Upgrades; PFS Underway
Published on 08/06/2026 at 01:40, 6 hours 31 minutes ago Taranis Identifies a Hydrothermally Altered, Sulfide-Bearing Intrusive Stock Associated with Historic Gold-Silver Occurrence and Connected to Thor
Published on 08/05/2026 at 23:40, 8 hours 31 minutes ago Galantas Gold Secures Key Permitting Approvals for Andacollo Gold Project
Published on 08/05/2026 at 23:10, 9 hours 1 minute ago Ur-Energy Announces Date for Second Quarter 2026 Results and Conference Call and Webcast
Published on 08/05/2026 at 23:01, 9 hours 10 minutes ago Full Circle Lithium Announces Extension of Current Private Placement
Published on 08/06/2026 at 08:05, 5 minutes ago Norlase Expands European Footprint with Direct Commercial Operations in Germany
Published on 08/06/2026 at 08:00, 11 minutes ago 11880 Solutions AG: EBITDA up by 82 per cent in the first half of 2026
Published on 08/06/2026 at 08:00, 11 minutes ago Pentixapharm Reports Second Quarter and First Half 2026 Results and Advances Phase 3 Panda Program
Published on 08/06/2026 at 08:00, 11 minutes ago Financial results Q2 2026 – Strong first half-year with profitable growth – Guidance confirmed – New partnerships formed
Published on 08/06/2026 at 08:00, 11 minutes ago EURAZEO ENTERS INTO EXCLUSIVE DISCUSSIONS WITH PARTNERS GROUP REGARDING THE CONTEMPLATED SALE OF ITS STAKE IN AROMA-ZONE AND ITS REINVESTMENT
Published on 08/05/2026 at 18:00, 14 hours 11 minutes ago Information concerning the total number of voting rights and shares in the share capital as of July 31, 2026
Published on 08/05/2026 at 17:49, 14 hours 21 minutes ago Mersen: Number of shares and voting rights as of July 31, 2026
Published on 08/05/2026 at 17:45, 14 hours 26 minutes ago Information concerning the total number of voting rights and shares 2026 07 31
Published on 08/05/2026 at 17:45, 14 hours 26 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
